Who this is for
Researcher-led teams and founders building innovations where women's health outcomes are central: therapeutics, diagnostics, devices, biomarkers, and digital tools with serious clinical intent.
You may sit in a university, hospital, institute, or early company. What matters is that you are close to decisions where evidence plans, regulatory shape, and venture milestones must line up — not whether you already call it a startup.
In scope (indicative)
- Defined problem, testable thesis, and a path to decision-grade evidence over time
- Willingness to work to staged milestones and explicit gate reviews
- Alignment with institutional governance and conflict-of-interest norms
- Need for translation support: regulatory, trial, reimbursement, or venture narrative — not only undifferentiated cash
Not in scope (indicative)
- Pure wellness or lifestyle products without a clinical evidence path proportionate to claims
- Projects that cannot articulate the next uncertainty to remove or the next capital or partner milestone
- Requests for medical advice, legal advice, or guaranteed investment — we are not a substitute for your advisors or investors
Final criteria will be published when program settings are confirmed.
What a strong candidate looks like (examples)
The lists above are deliberately high level. Below are illustrative examples only — not an exhaustive checklist or a guarantee of fit.
In scope — examples
- A university researcher with a novel endometriosis diagnostic that has completed proof-of-concept work but needs regulatory pathway mapping and clinical trial design support aligned to what investors and payers will ask for next.
- A hospital-linked team developing a device or digital tool for maternal or pelvic health where the next uncertainty is evidence shape, classification, or adoption in real clinical workflows — not simply building more features.
- An early company with a biomarker or therapeutic lead in women's health that can describe the next de-risking step and the milestone that would justify a larger funding round or partnership conversation.
- A digital health product with a serious clinical evidence path proportionate to its claims (for example, outcomes tied to guideline-relevant endpoints), not lifestyle positioning alone.
Out of scope — examples
- A consumer wellness app with no proportionate clinical evidence requirement or credible path to decision-grade outcomes.
- A general e-commerce or beauty brand reframed as“women's health” without a translational or evidence agenda.
- A request for undifferentiated grant funding with no articulated next uncertainty, partner milestone, or governance alignment.
What to expect if you register interest
- You submit role, contact details, and optional context (stage, institution, modality).
- We use that to triage outreach as program design and governance are finalised — not as a scored application.
- You may receive clarifying questions or information on next steps when intake processes open. Nothing in the form is an offer, admission, or funding commitment.
- When production workflows and privacy controls are live, you would receive a confirmation and notice at the email you provide. The current site may use a demonstration endpoint — see FAQ.
Practical support
Support is structured around recurring failure modes: regulatory and trial design choices, reimbursement and access realism, investable narrative, capital readiness, mentor access, and follow-on financing positioning with women's health context, not generic accelerator content.
- Milestone-based funding tied to de-risking steps
- Working sessions on evidence and regulatory path, not slide polishing alone
- Introductions when diligence readiness and partner timing align